Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
19.00
-0.01 (-0.05%)
At close: Nov 20, 2024, 4:00 PM
17.99
-1.01 (-5.32%)
Pre-market: Nov 21, 2024, 4:41 AM EST
Monopar Therapeutics Employees
As of December 31, 2023, Monopar Therapeutics had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees decreased by 2 or -16.67% compared to the previous year.
Employees
10
Change (1Y)
-2
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$647,473
Market Cap
100.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| FONAR | 520 |
| Harvard Bioscience | 416 |
| Karyopharm Therapeutics | 325 |
| PetMed Express | 287 |
| Quantum-Si incorporated | 159 |
| Immunic | 77 |
| Assembly Biosciences | 65 |
| Nuvectis Pharma | 13 |
MNPR News
- 12 days ago - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - GlobeNewsWire
- 21 days ago - Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock - GlobeNewsWire
- 23 days ago - Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock - GlobeNewsWire
- 23 days ago - Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 23 days ago - Up 600% Then Down 50% In 2 Days: What Is Going On With MNPR Stock? - Forbes
- 27 days ago - Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder - Benzinga
- 4 weeks ago - Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024 - GlobeNewsWire
- 5 weeks ago - Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers - GlobeNewsWire